South Africa’s antitrust watchdog has accused pharmaceutical company Adcock Ingram of profiteering from the Covid-19 pandemic ...
Competition Commission refers Adcock Ingram unit to tribunal over alleged excessive dialysis product pricing ...
South Africa’s antitrust watchdog has accused pharmaceutical company Adcock Ingram Holdings Ltd. of profiteering from the Covid-19 pandemic, according to people familiar with the matter.
The deal will still see Bidvest as the majority shareholder but will mean that the SA pharmaceutical group will be delisted from the JSE.
ICICI Securities recommended hold rating on Natco Pharma with a target price of Rs 1000 in its research report dated May 31, 2026.
Natco Pharma to acquire 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore, marking its entry into the African ...
JOHANNESBURG, Feb 21 (Reuters) - South African drugmaker Adcock Ingram (AIPJ.J), opens new tab said on Tuesday its margins would be under pressure over the next 12 months as a government-allowed price ...
Competition Commission is set to pursue claims that pharmaceutical company failed to pass on pandemic-era dialysis discounts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results